Who to call at Adaptive Biotechnologies Corporation, and when
Fundz watches for the moments Adaptive Biotechnologies Corporation starts buying, and tells you who to reach.
- An alert the day Adaptive Biotechnologies Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Adaptive Biotechnologies Corporation, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Adaptive Biotechnologies and Pfizer enter two significant partnerships worth up to $890 million for T-cell receptor research and AI drug discovery.
Dec 15, 2025
Contract Type
partnership
SeattleBiotechnologyHealth CareTherapeuticsDescription
Adaptive Biotechnologies has secured two agreements with Pfizer that could yield up to $890 million, focusing on T-cell receptor research for rheumatoid arthritis and AI applications. These partnerships validate Adaptive's technology platform and enable them to concentrate on target discovery, while Pfizer manages development and commercialization.
Related People
Agreement Insights
What this usually meansStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Adaptive Biotechnologies Corporation signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.